Degradation of pre-existing and newly synthesized extracellular matrix (ECM) is thought to play an important role in tissue remodeling. The current study evaluated whether thrombin and TNF /IL-1 could collaboratively induce collagen degradation by human fetal lung fibroblasts (HFL-1) and adult bronchial fibroblasts cultured in three-dimensional collagen gels.
Introduction
Alterations in tissue structure are characteristic of many chronic inflammatory diseases.
In the lung, tissue remodeling is believed to be the major cause for fixed airflow limitation that is the defining feature of chronic obstructive pulmonary disease and may be present in asthma (1, 2) . Tissue remodeling with loss of function also characterizes interstitial lung diseases. It is now clear that the lung can both produce new extra-cellular matrix and can cause its degradation.
Tissue remodeling, therefore, can result from an imbalance between extracellular matrix production and destruction.
The mechanisms that lead to extracellular matrix degradation are only partially defined.
In this context, the matrix metalloproteinases are believed to play a central role (3, 4) . This family of enzymes includes more than 20 different members that have a variety of substrate affinities (5) . The production of these enzymes is increased in many chronic diseases (6) (7) (8) .
Their activity, however, is regulated at several levels. Many proteases, which do not directly degrade extracellular matrix, for example, may contribute to matrix degradation by activating the matrix metalloproteinases (9) (10) (11) .
Thrombin is a serine protease activated in the final stages of the coagulation cascade.
Thrombin activation can occur as a result of intravascular coagulation and as a result of tissue injury (12) . Thrombin not only cleaves fibrinogen to fibrin but also has a number of other biological activities. In this context, thrombin can activate cell surface receptors and can modulate potential repair responses in a variety of cell types (13) (14) (15) .
Since thrombin, which does not directly degrade collagen, is likely to be present in inflammatory tissue injury where cytokines, such as IL-1 and TNF-, may drive the production of MMPs (16, 17) , the current study was designed to determine if an interaction between these pathways may occur in an in vitro model of tissue remodeling. Specifically, the cytokines IL-1 and TNF-were used to induce fibroblasts cultured in three-dimensional collagen gels to produce MMPs. Thrombin was then tested for its ability to activate these MMPs and lead to degradation of extracellular matrix. In addition, whether the actions of thrombin were mediated directly on the MMPs or indirectly through a cellular-mediated process were explored. The current study provides support for a synergistic interaction between thrombin and IL-1 /TNFin regulating extracellular matrix degradation by human lung fibroblasts.
Materials and Methods

Materials.
Type I collagen was extracted from rat tail tendons (RTTC) as previously described (18, 19) .
Briefly, tendons were excised from rat tails, and the tendon sheath and other connective tissues were removed carefully. Repeated washing with Tris-buffered saline (0.9% NaCl, 10mM Tris, pH7.5) was followed by dehydration and sterilization with 50%, 75%, 95% and pure ethanol.
Type I collagen was extracted in 6mM hydrochloric acid at 4°C for 24 h. The supernatant was harvested by centrifugation at 2,000 g for 2 h at 4°C. Protein concentration was determined by weighing a lyophilized aliquot from each lot of collagen solution. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) routinely demonstrated no detectable proteins other than type I collagen. The RTTC was stored at 4°C until use.
Thrombin from human plasma (Cat #T6884) and hirudin (Cat #7380) was purchased from Sigma (St. Louis, MO). MMP-1 and MMP-3 standards for immunobloting, TNF-and IL-1 were purchased from R&D Systems, Inc. (Minneapolis, MN). Tissue culture supplements, fetal calf serum (FCS) and media were purchased from Invitrogen (Carlsbad, CA).
Cell culture.
Human fetal lung fibroblasts (HFL-1) were obtained from the American Type Culture Collection (Rockville, MD). Human adult bronchial fibroblasts (HBF) were isolated as primary cultures from bronchial biopsies tissues obtained from normal smokers. After expansion, the cells were cultured in 100-mm tissue culture dishes (FALCON; Becton-Dickinson Labware, Franklin Lakes, NJ) in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10%FCS, 50 U/ml penicillin, 50 Ig/ml streptomycin, and 1 Ig/ml fungizone. The fibroblasts were passaged every 3-5 d and, at passage 2-3 were stored under liquid nitrogen vapor until use.
Frozen cells were thawed, cultured as described above and subconfluent fibroblasts were trypsinized (trypsin-EDTA; 0.05% trypsin, 0.53mM EDTA-4Na) and used for collagen gel culture. HFL-1 fibroblasts used in these experiments were between cell passage 14 and 19, and HBFs were between passage 4 and 6 after initial isolation.
Collagen gel preparation.
Collagen gels were prepared as described previously (19) . Briefly, the appropriate amount of RTTC was mixed with distilled water, 4X concentrated DMEM, and the cell suspension so that the final mixture resulted in 0.75 mg/ml of collagen, 4.5 ×10 5 cells/ml, and a physiologic ionic strength. Fibroblasts were routinely added last to minimize damage during the preparation of collagen gels. One half milliliter of the mixture, which contains approximately 375Ig collagen, was cast into each well of 24-well tissue culture plates (FALCON, Becton Dickinson Labware, Franklin Lakes, NJ). Gelation occurred in about 20 min at room temperature, after which the gels were released and transferred to 60-mm tissue culture dishes containing 5 ml of serum-free DMEM with or without thrombin or the cytokines (TNF-and IL-1 ). The floating gels were then incubated at 37°C in a 5% CO 2 atmosphere for various periods of time. In order to determine if thrombin catalytic activity was required, thrombin (500nM, which equals 56U/ml) was neutralized with the specific inhibitor hirudin (2.5IM, which equals 84U/ml). To accomplish this, thrombin and hirudin were added to the culture medium and incubated at 37°C for 30 min prior to the addition of cytokines.
Hydroxyproline assay.
Hydroxyproline, which is directly proportional to type I collagen content, was measured by spectrophotometry (20) . Briefly, the collagen gels were transferred to microcentrifuge tubes and centrifuged (2,000g, 10 min.), and the supernatant was removed. The gel was then solubilized by heating in ddH2O (50IL/gel). Samples (20 µl) mixed with 30 µl 3. 
Gelatin zymography.
To investigate the activity of gelatinases (MMP-2 and -9), gelatin zymography was performed. The conditioned media (500IL per culture condition) were concentrated 10-fold by precipitation with cold ethanol and dissolved in distilled H 2 O (50IL per sample). The same amount of medium from each condition was used. This makes it possible to compare the absolute amounts of MMPs in the various cultures. Gelatin zymography was performed by a modification of previously published procedures (17) . The samples were dissolved in 2 X electrophoresis sample buffer without 2-mercaptoethanol and analyzed in 10% SDS-PAGE containing 0.1% gelatin under non-reducing conditions. After electrophoresis, the gels were soaked in 2.5% (v/v) Triton-X 100 and gently shaken at room temperature for 1 h. The gels then were incubated in metalloproteinase activation buffer (50mM Tris-HCl, pH7.5, containing 5 mM 
Immunoblot Analysis of Metalloproteinases.
To further identify the production of MMPs, immunoblots were performed. The supernatants (5 ml per condition) from 3-dimensional culture were precipitated with 50% 
RNA isolation and complementary DNA synthesis.
Collagen gels were digested with collagenase (0.5mg/ml in RNAse-free PBS) at 37°C for 1h. Total RNA was then extracted from the cell pellets with acid guanidine monothiocyanate, and precipitated with isopropylalcohol. The extracted RNA was dissolved in TE buffer (10mM Tris-HCl, PH7.4, 1mM EDTA) and the total amount was quantified spectrophotometrically. One µg of total RNA was treated with DNAse I following the manufacturer's instructions (Invitrogen) for 15 min at room temperature to remove possible contaminating genomic DNA. The reaction was then stopped with 25mM EDTA by heating at 65°C for 10 min, followed by 95°C for 5 min.
For cDNA synthesis, 400ng of DNAse-treated RNA was transcribed with cDNA transcription reagents (Applied Biosystems, Branchburg, NJ) by using random hexamers, and the cDNA was used for quantitative real-time PCR.
Quantitative real-time polymerase chain reaction (PCR).
Gene expression was measured with the use of the ABI PRISM 7700 Sequence Detection System (Applied Biosystems, Branchburg, NJ) as described previously (21) . Primers and TaqMan probes were designed using the Primer ExpressTM 1.0 (Applied Biosystems) software to amplify <150 base pairs. Probes were labeled at the 5` end with the reporter dye molecule 6-carboxy-fluorescein (FAM) (22) and at the 3` end with the quencher dye molecule 6-carboxytetramethyl-rhodamine (TAMRA). The target gene and the housekeeping gene Thermal cycle parameters included 2 min at 50°C, 10 min at 95°C, and 40 cycles involving denaturation at 95°C for 15 sec and annealing /extension at 60°C for 1 min.
Statistical analysis.
Individual experiments included triplicate gels for all experimental conditions. Results were always confirmed by repeating each experiment on separate occasions at least three times.
Statistical comparisons were made from all experiments, including both the within and between group variance. Pooled data are expressed as % or fold of control condition. Group data were analyzed by one-way ANOVA followed by Tukey test. Differences of paired data were assessed by Students t-test. P<0.05 was considered significant.
RESULTS
The Effect of Thrombin and Cytokines on Collagen Gel Degradation
To determine if thrombin together with cytokines (TNF-5ng/ml and IL-1 5ng/ml) would induce collagen gel degradation, hydroxyproline content within the gels was determined ( Figure 1A) . No effect on gel degradation was observed when cells were exposed to either cytokines or thrombin (5nM, 50nM, 500nM) alone (hydroxyproline content within gels was 80.7±5.4% to 89.9±1.8% of control, p>0.05). In contrast, when added together with cytokines, thrombin (500nM) together with IL-1 /TNF-resulted in nearly complete degradation of the collagen populated with HFL-1 cells (hydroxyproline content was 9.1±2.9% of control, p<0.01).
In the presence of thrombin inhibitor (hirudin), cytokines plus thrombin did not cause collagen degradation (Fig 1B) . Similar results were observed in HBF populated collagen gels (data not shown).
To determine whether thrombin directly or indirectly activates MMPs, fibroblast-conditioned media were prepared by culturing the cells in 3-dimensional collagen gels with or without cytokine stimulation. Collagen gels without cells were then incubated with the fibroblast-conditioned media in the presence or absence of thrombin and hydroxyproline content was determined after 24 hours of incubation. Fibroblast-conditioned media alone or thrombin was added to control-conditioned medium did not degrade collagen gels. However, when thrombin was added to cytokine-conditioned medium, collagen gels were degraded significantly ( Fig 1C, hydroxyproline content was 58.7±3.4% of control, p<0.01) although the degradation was not as complete as that observed in the presence of cells.
Effect of Thrombin and Cytokines on Gelatinase Production and Activation
To determine if thrombin altered fibroblast production of collagen degrading enzymes several experiments were performed, First, zymography was performed to examine the effect of thrombin and cytokines on gelatinase (MMP-2 and MMP-9) production and activation (Figure 2 ).
Under control conditions, both HFL-1 fibroblasts and adult bronchial fibroblasts cultured in 3-dimensonal collagen gels released MMP-2 in both the latent and active forms, but no MMP-9 was detected. In response to stimulation by cytokines (TNF-5ng/ml and IL-1 5ng/ml), MMP-9 (latent form) and increased amounts of MMP-2 (both latent form and active form) were detected in HFL-1 cells (Fig 2A) . In the presence of cytokines, thrombin concentration-dependently stimulated MMP-9 activation in HFL-1 cells (Fig 2A) . Nearly all MMP-9 was present as the active form in cultures incubated with 500nM thrombin in HFL-1 cells (Figure 2A) , and this was completely blocked by hirudin (Fig 2B) . Consistently, collagen degradation was completely blocked by hirudin in HFl-1 cell populated gels (Fig 1B) . Similar results were obtained with adult human bronchial fibroblasts (HBF, Fig 2C) . Under control conditions, HBFs release MMP-2, but not MMP-9. In addition, HBF in 3-dimensional collagen gel culture also produce other un-identified gelatinases corresponding in size to 45-50kDa ( Figure 2C ).
In contrast to HFL-1 fibroblasts, both thrombin and cytokines alone stimulated MMP-9 production by HBFs, and also resulted in activated MMP-9. These effects were significantly augmented when both cytokines and thrombin were added together ( Figure 2C ).
Effect of Thrombin and Cytokines on MMP-1 and MMP-3 Production and Activation
To determine the effect of thrombin and cytokines on MMP-1 and MMP-3 expression, immunoblotting was performed (Figure 3) . Under control conditions, a small amount of MMP-1 in the latent form was produced by both HFL-1 or HBF cells ( Figure 3A and C) . Cytokines (TNF-5ng/ml and IL-1 5ng/ml) alone markedly induced MMP-1 release, and this was detected in the latent form. When thrombin was added together with cytokines, MMP-1 was subsequently converted to a lower molecular weight form corresponding to the active form of MMP-1. In the presence of cytokines, incubation with thrombin at the concentration of 500nM resulted in most of the MMP-1 being present as the active form ( Figure 3A and C). Figure 3B and D) . Thrombin alone at concentrations (5nM and 50nM) had no effect on MMP-3 release by HFL-1 cells ( Figure 3B) . A higher concentration of thrombin (500nM), however, stimulated HFL-1 cells to produce a small amount of MMP-3 in the lower molecular weight form corresponding to the active form ( Figure   3B ), while both latent and active MMP-3 were detected in HBF samples ( Figure 3D ). Cytokines (TNF-5ng/ml and IL-1 5ng/ml) induced readily detectable latent MMP-3, and in the presence of thrombin this was converted to the active form in a concentration-dependent manner ( Figure   3B ). Similar findings were observed in HBFs cultured in the three-dimensional collagen gels ( Figure 3D ).
MMP-3 was undetectable under control conditions (
Effect of Thrombin and Cytokines on TIMP-1 Release
TIMP-1, an inhibitor of MMPs, was measured by ELISA (Figure 4) . HFL-1 fibroblasts cultured in 3-dimensional collagen gels released large amounts of TIMP-1. Thrombin added alone had no effect on TIMP-1 release. Cytokines (TNF-5ng/ml and IL-1 5ng/ml) inhibited TIMP-1 release (64.1±6.9% of control condition, p<0.05). Co-exposure to thrombin and cytokines further reduced TIMP-1. The TIMP-1 level was 60.1±7.9%, 61.1±8.3% and 54.8±5.0% of control (p<0.01) when thrombin (5nM, 50nM and 500nM) and cytokines were added together.
Effect of Thrombin and Cytokines on MMP-1, MMP-3, MMP-9 and TIMP-1 mRNA production
To determine whether the changes in MMP and TIMP release were associated with changes in gene expression, RT-PCR was performed. MMP-1 and MMP-3 mRNA were detected under control conditions. Cytokines (TNF-5ng/ml and IL-1 5ng/ml) significantly stimulated MMP-1 and MMP-3 mRNA levels ( Figure 5A, B) . MMP-1 and MMP-3 mRNA was 2.4±0.5 and 50±9 fold of control (p<0.01) following stimulation by cytokines. Thrombin (500nM) had no effect on MMP-1 and MMP-3 mRNA expression either alone or in combination with IL-1 /TNF-(p>0.05).
Little MMP-9 mRNA was detected under control conditions. Cytokines (TNF-5ng/ml and IL-1 5ng/ml) alone significantly stimulated MMP-9 mRNA expression (MMP-9 mRNA was 530±270 fold of control, p<0.01). Thrombin (500nM) by itself had no effect on MMP-9 mRNA production, but further increased MMP-9 mRNA when added together with cytokines ( Figure 5C ). Co-exposure to thrombin (500nM) and cytokines increased MMP-9 mRNA to 2200±400 fold of control (p<0.01).
TIMP-1 mRNA expression was observed under control conditions. Both cytokines (TNF5ng/ml and IL-1 5ng/ml) and thrombin (500nM) added alone resulted in a small decrease of the TIMP-1 mRNA, which was not statistically significant (88.3±4.3% and 90.0±5.0% of control respectively, p>0.05). TIMP-1 mRNA, however, was significantly inhibited by the combination of thrombin and cytokines to 74.9±2.9% of control (p<0.01) ( Figure 5D ).
The Direct Effect of Thrombin on MMP-1, MMP-2, MMP-3 and MMP-9 Activation
To further determine whether thrombin could directly activate MMPs, conditioned medium was incubated with thrombin (5nM or 500nM) and then analyzed for MMP activation.
MMP-2 and MMP-9 were evaluated by zymography ( Figure 6 ). In supernatant from HT1080 cell monolayer culture, both MMP-2 and MMP-9 were detected in latent form. Lower concentrations of thrombin (5nM) had no effect on MMP-2 and MMP-9 activation. Thrombin at higher concentration (500nM), however, significantly resulted in conversion of both MMP-2 and MMP-9 into lower molecular weight forms corresponding to the active MMPs. This contrasts with the effect of 5nM thrombin added in the presence of fibroblasts, where activation of MMP-9 was readily observed (Figure 2A ).
MMP-1 and MMP-3 were analyzed by immunoblotting. Fibroblast-conditioned media were acquired by culturing HFL-1 cells in 3-dimensional collagen gels with or without cytokine stimulation. In the control-conditioned medium, MMP-1 and MMP-3 were not detected, and there was no effect when the control-conditioned medium was incubated with thrombin. In the presence of cytokines, MMP-1 and MMP-3 were released in latent form, which could be readily detected. Even with relatively heavily loaded gels, however, no MMP-1 or MMP-3 in the lower molecular weight form was detected. In contrast, in the presence of thrombin (500nM) lower molecular weight forms of both MMP-1 and MMP-3, corresponding to the active forms were easily detected and represented most of the MMPs present following incubation ( Figure 7A,   B ).
Discussion
The current study demonstrates that thrombin together with the inflammatory mediators TNF-and IL-1 synergistically induces collagen degradation within three-dimensional collagen gels populated by human fetal lung fibroblasts. This synergy occurs because the cytokines (TNF-and IL-1 ) induce the fibroblasts to produce and secrete matrix metalloproteases including MMP-1, 2, 3 and 9. These MMPs, however, are released in latent form. Thrombin, which has no effect on collagen degradation when added alone, results in conversion of the MMPs from their latent to their active forms, thus resulting in collagen degradation. Hirudin, which is an inhibitor of thrombin activity, blocks thrombin-induced MMP activation and collagen gel degradation indicating that thrombin proteolytic activity is required. Thrombin is a serine protease that cleaves fibrinogen to fibrin in the final steps of the clotting cascade (12) . Activation of thrombin, therefore, is a key and highly regulated step in coagulation.
Thrombin, however, has a number of other important biological activities. Thrombin is capable of cleaving the protease-activated receptors PAR1, 3 and 4, which are present on the surface of many cell types (13, 14) . Through these activities, thrombin is believed to participate in repair and remodeling responses by stimulating fibroblast migration, proliferation and differentiation, and productions of extracellular matrix and growth factors (24) (25) (26) (27) (28) . Consist with a role in the lung, increased levels of thrombin are reported in BAL fluid following allergen challenge in asthma, and are believed to contribute to the activity of BAL on fibroblasts (29) . Thrombin may also modulate epithelial cell responses, including apoptosis (30) and induction of mucin gene expression (31) . These multiple activities of thrombin are consistent with the concept that coagulation, repair and remodeling are highly linked processes.
Thrombin has been reported to directly activate pro-MMP-2 in cultured vascular smooth muscle cells (9) . In this previous report, however, thrombin activation of MMP-2 took place at the cell surface. The current report demonstrates that thrombin is capable of activating MMP-2 in the absence of fibroblasts. Thrombin was added to conditioned medium that contained several latent MMPs. Following incubation with thrombin, active MMP-1, MMP-2, MMP-3
and MMP-9 were observed. Since MMP-3, when activated, is capable of activating MMP-2 and MMP-9 (32), the present study cannot distinguish whether thrombin is directly activating all the MMPs evaluated or whether it initiates a protease cascade. The current study does, however, establish that thrombin is capable of leading to MMP activation in the absence of cells.
A cell-dependent action of thrombin, however, is also supported by the current study. In this context, thrombin has been reported to be a potent stimulator of MMP-9 gene expression in human mesangial cells (33) . The current study did not observe an effect of thrombin alone on MMP-9 expression in HFL-1 cells. However, the induction of MMP-9 mRNA expression that was induced by TNF-and IL-1 was markedly potentiated by the addition of thrombin. This synergistic effect on MMP-9 appeared to be specific, as the induction of MMP-1 and MMP-3 mRNA, which was also observed with IL-1 and TNF-, was unaffected by the addition of thrombin. The data from the current study, therefore, suggest that thrombin can interact with the MMP system both directly in the extracellular milieu and indirectly through actions requiring cell-dependent processes.
HFL-1 cells are a widely used strain of human fetal lung fibroblasts. They are easily cultured in vitro, give reproducible results and, since they have been widely used, allow comparisons among various investigators. Both fetal and adult human lung fibroblasts can produce extracellular matrices (e.g. fibronectin and collagen), growth factors (e.g. TGF-1), and can mediate collagen gel contraction (34) (35) (36) (37) . However, many phenotypic differences between fetal and adult human lung fibroblasts have been reported. For instance, fetal lung fibroblasts have a higher proliferation rate and are more sensitive to oxidative damage compared to adult lung fibroblasts (35) (36) (37) . While the mechanisms for the differences between adult and fetal cells remain to be defined, in the current study, MMPs were produced and activated in both fetal and adult human lung fibroblasts in response to cytokine stimulation and thrombin activation. This suggests these processes may be a general feature of lung fibroblasts. However, the effect of thrombin on MMP-9 appears to be cell-type dependent in that thrombin alone had no effect on MMP-9 expression by HFL-1 cells, but thrombin did stimulate release of MMP-9 from adult bronchial fibroblasts. This suggests that the response of fetal and adult cells to inflammation and injury, while generally similar, may differ in detail.
The cytokines IL-1 and TNF-are believed to be "upstream" cytokines. Their release early in an inflammatory event is believed to initiate a cascade of complex inflammatory mediators . fibroblasts cultured in 3-dimensional collagen gels were stimulated with or without cytokines (5ng/ml TNF-and 5ng/ml IL-1 ). After 4 days, the conditioned media were exposed to thrombin (0nM and 500nM) for 24hr, the media were harvested and immunoblotting was used to 
